Enliven Therapeutics Inc Company Profile

Enliven Therapeutics Announces Q1 Financial Results and ...

Enliven Therapeutics, Inc., a clinical-stage precision oncology company, announced significant progress in its pipeline and financial ...

Enliven Therapeutics, Inc. Common Stock (ELVN) Institutional ...

About Institutional Holdings. Nasdaq provides the ownership stake information in a company, including the number of shares held by those institutions in a firm, ...

ELVN | Enliven Therapeutics Inc. Stock Overview (U.S.: Nasdaq)

Enliven Therapeutics Inc. ; Day Range24.62 - 27.20 ; 52 Wk Range9.80 - 30.03 ; Volume, 242.26K ; Market Value, $1.22B ; EPS (TTM), -$1.91.

Enliven Therapeutics, Inc (ELVN) Reports Positive Proof of Concept ...

ELVN-001 has been well tolerated, consistent with its selective kinase profile. · A maximum tolerated dose has not been identified, and there ...

ELVN - Enliven Therapeutics, Inc. Latest Stock News & Market ...

Enliven Therapeutics, Inc. (Nasdaq: ELVN) is a clinical-stage biopharmaceutical company dedicated to discovering and developing next-generation small molecule ...

Enliven Therapeutics begins patient dosing in oncology drug trial

Enliven Therapeutics Inc. (Nasdaq: ELVN), a clinical-stage precision oncology company, began dosing patients in clinical trials for two of its drug candidates.

Anish Patel - ELVN | Enliven Therapeutics Inc. - Wall Street Journal

Anish Patel founded Enliven Therapeutics, Inc. and Enliven Therapeutics, Inc. Dr. Patel holds the position of Chief Operating Officer at Enliven ...

ELVN-001 Appears Safe and Effective in Relapsed/Refractory CML

... profile. Despite recent advancements in the CML treatment ... Enliven Therapeutics, Inc. September 28, 2024. Accessed October 7 ...

Enliven Therapeutics, Inc. (ELVN) - 8-K Material Event Fri Jun 23 2023

Enliven Therapeutics, Inc. (ELVN) SEC Filing 8-K Material Event for ... Income Taxes - Summary Of Company's Deferred Income Taxes (Details).

Enliven Therapeutics Announces Positive Proof of Concept Data ...

Enliven Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help ...

Enliven Therapeutics: Preclinical Company With Interesting Value ...

Enliven Therapeutics, Inc., a biopharma company, raised $165M to develop oncology candidates for leukemia and lymphoma.

With 36% stake, Enliven Therapeutics, Inc. (NASDAQ:ELVN) seems ...

A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.

Enliven Therapeutics Financial Overview, Employee Count ... - Apollo

Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live ...

Jefferies initiated coverage on Enliven Therapeutics with a new ...

BOULDER, Colo., Nov. 7, 2024 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (NASDAQ:ELVN), a clinical-stage biopharmaceutical company ...

Enliven Therapeutics - 1 Year Stock Price History | ELVN

Enliven Therapeutics Inc. is a clinical-stage precision oncology company focused on the discovery and development of small molecule kinase inhibitors.

Ian Scott - VP CMC at Enliven Therapeutics - The Org

In 2005, they joined Acucela Inc. as the Senior Director, Chemistry and ... Eric Jackson's profile picture. Eric Jackson. Rasmussen College and Online ...

Pipeline | BCR-ABL | ELVN-001 | HER2 | Enliven Therapeutics

We are focused on the discovery and development of potentially best-in-class or first-in-class precision oncology therapies. To achieve this, we aim to ...

Enliven Therapeutics Inc USD0.001 share price

Enliven Therapeutics Inc (ELVN) USD0.001 ; Previous close · $27.63 ; Trade low · $26.07 ; Year low · $9.85 ; Previous · $1.33 ; Volume · n/a.

Statement of Changes in Beneficial Ownership - Form 4 - Public now

Enliven Therapeutics, Inc. [ELVN], 5. Relationship of Reporting ... Company News | Shareholders | Buyback, Treasury Shares and Liquidity ...

ELVN - Enliven Therapeutics, Inc. Stock - Share Price, Short Interest ...

Short Sale volume shows the number of trades marked as short sales in various trading venues. For more information on how to interpret this data, read this ...